As our results showed that EXOKV11 could inhibit vascular leakage and limit the F4/80 infiltration in VEGF-treated retinas, further studies would be required to test whether EXOKV11 could also be the potential treatment for wet AMD. Here, VEGFA is linked to wet macular degeneration.